Minastrin 24 Fe Shortage: What Providers and Prescribers Need to Know in 2026

The brand-name Minastrin 24 Fe (norethindrone acetate 1 mg/ethinyl estradiol 20 mcg chewable tablet with ferrous fumarate, 24-day active regimen) manufactured by Allergan has been permanently discontinued. Patients who were previously prescribed this specific brand are now encountering pharmacy-level confusion, billing issues, and anxiety about their birth control coverage. This guide is designed to help providers navigate the transition efficiently and minimize disruption to patients.

Clinical Background: What Was Minastrin 24 Fe?

Minastrin 24 Fe was a combination oral contraceptive (COC) consisting of 24 active chewable tablets containing norethindrone acetate 1 mg and ethinyl estradiol 20 mcg, followed by 4 brown iron tablets (ferrous fumarate 75 mg) serving as placebo. The 24-day active / 4-day placebo schedule (versus the traditional 21/7 regimen) was designed to reduce hormone-free interval length, resulting in lighter, more predictable withdrawal bleeding and lower rates of amenorrhea.

The chewable spearmint-flavored formulation was a distinguishing feature, offering an alternative for patients who had difficulty swallowing standard tablets. The product was indicated solely for contraception; it was not FDA-approved for acne or PMDD (unlike drospirenone-containing COCs).

What Pharmacies Are Dispensing Now

When pharmacists receive a prescription for "Minastrin 24 Fe," they are dispensing AB-rated generic equivalents. Currently active generics in this drug class include:

Charlotte 24 Fe (norethindrone acetate 1 mg/EE 20 mcg, 24/4)

Mibelas 24 Fe (norethindrone acetate 1 mg/EE 20 mcg, 24/4)

Blisovi 24 Fe (norethindrone acetate 1 mg/EE 20 mcg, 24/4)

Gildess 24 Fe, Hailey 24 Fe, Aurovela 24 Fe 1/20, Tarina 24 Fe, Microgestin 24 Fe, Lomedia 24 Fe

Note that not all of these generics are available as chewable tablets. Some are dispensed as standard film-coated tablets on the same 24/4 schedule. Availability varies by pharmacy, region, and current wholesaler inventory.

Prescribing Recommendations: How to Write Flexible Prescriptions

The most important clinical action for providers right now is updating any standing prescription for "Minastrin 24 Fe" to a generic-friendly format. Recommended language:

"Norethindrone acetate 1 mg / ethinyl estradiol 0.020 mg tablet (or chewable tablet if available) with ferrous fumarate 75 mg — 24 active tablets / 4 placebo tablets — dispense any AB-rated equivalent — generic substitution permitted"

If chewable form is clinically important (e.g., patient has documented swallowing difficulty), specify that clearly. Otherwise, permitting either chewable or swallowable tablets maximizes pharmacy flexibility.

Therapeutic Alternatives If Generic Supply Is Unavailable

If a patient cannot locate any of the direct generic equivalents, consider the following therapeutic alternatives:

Norethindrone acetate 1 mg/EE 20 mcg — 21-day schedule (Junel Fe 1/20, Microgestin Fe 1/20, Blisovi Fe 1/20): Same hormones, different schedule. Patients may experience a slightly longer hormone-free interval (7 days vs 4 days), which can increase cycle variability. Widely available and very low cost with discount cards ($9-$15/pack).

Lo Loestrin Fe (norethindrone acetate 1 mg/EE 10 mcg, 24/2/2): Lower estrogen dose; may cause more breakthrough bleeding initially. Appropriate for patients who tolerate norethindrone acetate but prefer minimal estrogen exposure.

Drospirenone/EE 3mg/20mcg (Yaz generics): Different progestin; also uses 24/4 schedule. Consider for patients with acne or PMDD who may benefit from the anti-androgenic properties of drospirenone.

39,333+ patients found their medications in stock

39K+

Find Ovide In Stock Today →

Insurance and Formulary Considerations

Under the ACA contraceptive coverage mandate, commercial plans must cover at least one form of each FDA-approved contraceptive method without cost-sharing. Since Minastrin 24 Fe is discontinued:

Most plans will automatically cover a generic equivalent at $0 without prior authorization

If a patient needs a specific generic not on formulary, a medical necessity exception is typically straightforward to document

Medicaid coverage varies by state; patients on Medicaid should verify covered alternatives with their state plan

Patient Counseling Key Points

Reassure patients that generic equivalents are bioequivalent—same hormones, same efficacy, same safety profile

For patients switching between generics on the same schedule, no backup contraception is required as long as no pills are missed

If switching to a different schedule (e.g., 21-day), counsel patients on timing and the 7-day backup rule

Remind patients to verify their specific generic is covered by their insurer before filling

Skip the calls, skip the stress.

Find Ovide In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Tools for Patients Finding Their Medication

If patients are struggling to locate a specific generic at their pharmacy, direct them to medfinder for providers. medfinder calls pharmacies to check real-time stock availability for a specific medication and texts results to the patient, saving significant time for both patient and practice staff.